Neurobiology of nicotine dependence

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 363, Issue 1507, 2008, Pages 3159-3168

  Markou, Athina ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dependence; Glutamate; Nicotine; Reinstatement; Withdrawal; aminobutyric acid

Indexed keywords

BRAIN; DRUG; NEUROLOGY; SMOKING; TOBACCO;

ANIMALIA; NICOTIANA TABACUM;

4 AMINOBUTYRIC ACID; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; GLUTAMATE RECEPTOR; NICOTINIC RECEPTOR;

HUMAN; METABOLISM; NEUROBIOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SYNAPSE; TOBACCO DEPENDENCE; VENTRAL TEGMENTUM; WITHDRAWAL SYNDROME;

GAMMA-AMINOBUTYRIC ACID; HUMANS; NEUROBIOLOGY; NEUROTRANSMITTER AGENTS; RECEPTORS, GLUTAMATE; RECEPTORS, NICOTINIC; SUBSTANCE WITHDRAWAL SYNDROME; SYNAPSES; TOBACCO USE DISORDER; VENTRAL TEGMENTAL AREA;

EID: 51449108819     PISSN: 09628436     EISSN: None     Source Type: Journal    
DOI: 10.1098/rstb.2008.0095     Document Type: Conference Paper

References (80)

1. Anthony, J. C., Warner, L. A. & Kessler, R. C. 1994 Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the National Comorbidity Survey. Exp. Clin. Psychopharmacol. 2, 244-268. (doi:10.1037/1064-1297.2.3.244)
2. Bardo, M. T., Green, T. A., Crooks, P. A. & Dwoskin, L. P. 1999 Nornicotine is self-administered intravenously by rats. Psychopharmacologia 146, 290-296. (doi:10.1007/s002130051119)
3. Belluzzi, J. D., Wang, R. & Leslie, F. M. 2005 Acetaldehyde enhances acquisition of nicotine self-administration in adolescent rats. Neuropschopharmacology 30, 705-712. (doi:10.1038/sj.npp.1300586)
4. Bespalov, A. Y., Dravolina, O. A., Sukhanov, I., Zakharova, E., Blokhina, E., Zvartau, E., Danysz, W., van Heeke, G. & Markou, A. 2005 Metabotropic glutamate receptor (mGluR5) antagonist MPEP attenuated cue- and schedule-induced reinstatement of nicotine self-administration behavior in rats. Neuropharmacology 49(Suppl. 1), 167-178. (doi:10.1016/j. neuropharm.2005.06.007)
5. Besson, M. et al. 2007 Long-term effects of chronic nicotine exposure on brain nicotinic receptors. Proc. Natl Acad. Sci. USA 104, 8155-8160. (doi:10.1073/pnas.0702698104)
6. B agonists in the treatment of psychostimulant addiction. Alcohol Alcohol. 37, 478-484.
7. Buisson, B. & Bertrand, D. 2001 Chronic exposure to nicotine upregulates the human α4β2 nicotinic acetylcholine receptor function. J. Neurosci. 21, 1819-1829.
8. Buisson, B. & Bertrand, D. 2002 Nicotine addiction: the possible role of functional upregulation. Trends Pharmacol. Sci. 23, 130-136. (doi:10.1016/S0165-6147(00)01979-9)
9. Changeux, J.-P. & Taly, A. 2008 Nicotinic receptors, allosteric proteins and medicine. Trends Mol. Med. 14, 93-102. (doi:10.1016/j.molmed.2008.01.001)
10. Changeux, J.-P., Devillers-Thiery, A. & Chemouilli, P. 1984 Acetylcholine receptor: an allosteric protein. Science 225, 1335-1345. (doi:10.1126/science.6382611)
11. Chaudhri, N., Caggiula, A. R.,Donny, E. C., Palmatier, M. I., Liu, X. & Sved, A. F. 2006 Complex interactions between nicotine and nonpharmacological stimuli reveal multiple roles for nicotine in reinforcement. Psychopharmacology 184, 353-366. (doi:10.1007/s00213-005-0178-1)
12. Corrigall, W. A. & Coen, K. M. 1991 Selective dopamine antagonists reduce nicotine self-administration. Psychopharmacology 104, 171-176. (doi:10.1007/BF02244174)
13. Corrigall, W. A., Franklin, K. B. J., Coen, K. M. & Clarke, P. B. S. 1992 The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology 107, 285-289. (doi:10.1007/BF02245149)
14. Corrigall, W. A., Coen, K. M. & Adamson, K. L. 1994 Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res. 653, 278-284. (doi:10.1016/0006-8993(94)90401-4)
15. Corrigall, W. A., Coen, K. M., Adamson, K. L., Chow, B. L. C. & Zhang, J. 2000 Response of nicotine self-administration in the rat to manipulations of mu-opioid and γ-aminobutyric acid receptors in the ventral tegmental area. Psychopharmacology 149, 107-114. (doi:10.1007/s002139900355)
16. Corrigall, W. A., Coen, K. M., Zhang, J. & Adamson, K. L. 2001 GABA mechanisms in the pedunculopontine tegmental nucleus influence particular aspects of nicotine self-administration selectively in the rat. Psychopharmacology 158, 190-197. (doi:10.1007/s002130100869)
17. Crooks, P. A. & Dwoskin, L. P. 1997 Contribution of CNS nicotine metabolites to the neuropharmacological effects of nicotine and tobacco smoking. Biochem. Pharmacol. 54, 743-753. (doi:10.1016/S0006-2952(97) 00117-2)
18. B receptor-positive modulator GS39783 (N,N′- dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines. J. Pharmacol. Exp. Ther. 310, 952-963. (doi:10.1124/jpet.104.066753)
19. Dani, J. A. & Heinemann, S. 1996 Molecular and cellular aspects of nicotine abuse. Neuron 16, 905-908. (doi:10.1016/S0896-6273(00) 80112-9)
20. DeNoble, V. J. & Mele, P. C. 1983 Behavioral pharmacology annual report. Philip Morris collection. Bates no. 1003060364/0441. See http://legacy.library.ucsf.edu/tid/wot74e00.
21. Dewey, S. L. et al. 1998 A novel strategy for the treatment of cocaine addiction. Synapse 30, 119-129. (doi:10.1002/(SICI)1098- 2396(199810)30:2<119::AID-SYN1>3.0. CO;2-F)
22. Dewey, S. L., Brodie, J. D., Gerasimov, M., Horan, B., Gardner, E. L. & Ashby Jr, C. R. 1999 A pharmacologic strategy for the treatment of nicotine addiction. Synapse 31, 76-86. (doi:10.1002/(SICI)1098- 2396(199901)31: 1<76::AID-SYN10>3.0.CO;2-Y)
23. Epping-Jordan, M. P.,Watkins, S. S., Koob, G. F. & Markou, A. 1998 Dramatic decreases in brain reward function during nicotine withdrawal. Nature 393, 76-79. (doi:10.1038/30001)
24. Fattore, L., Cossu, G., Martellotta, M. C. & Fratta, W. 2002 Baclofen antagonizes intravenous self-administration of nicotine in mice and rats. Alcohol Alcohol. 37, 495-498.
25. Flores, C. M., Davila-Garcia, M. I., Ulrich, Y. M. & Kellar, K. J. 1997 Differential regulation of neuronal nicotinic receptor binding sites following chronic nicotine administration. J. Neurochem. 69, 2216-2219.
26. Fu, Y., Matta, S. G., Gao, W., Brower, V. G. & Sharp, B. M. 2000 Systemic nicotine stimulates dopamine release in nucleus accumbens: re-evaluation of the role of N-methyl-D-aspartate receptors in the ventral tegmental area. J. Pharmacol. Exp. Ther. 294, 458-465.
27. Gentry, C. L., Wilkins Jr, L. H. & Lukas, R. J. 2003 Effects of prolonged nicotinic ligand exposure on function of heterologously expressed, human α4β2- and α4β4-nicotinic acetylcholine receptors. J. Pharmacol. Exp. Ther. 304, 206-216. (doi:10.1124/jpet.102. 041756)
28. B receptors. Bioorg. Med. Chem. Lett. 17, 6206-6211. (doi:10.1016/j.bmcl.2007.09.023)
29. Guillem, K., Vouillac, C., Azar, M. R., Parsons, L. H., Koob, G. F., Cador, M. & Stinus, L. 2006 Monoamine oxidase A rather than monoamine oxidase B inhibition increases nicotine reinforcement in rats. Eur. J. Neurosci. 24, 3532-3540. (doi:10.1111/j.1460-9568.2006.05217.x)
30. Haas, A. L., Munoz, R. F., Humfleet, G. L., Reus, V. I. & Hall, S. M. 2004 Influences of mood, depression history, and treatment modality on outcomes in smoking cessation. J. Consult. Clin. Psychol. 72, 563-570. (doi:10.1037/0022-006X.72.4.563)
31. Harrison, A. A., Gasparini, F. & Markou, A. 2002 Nicotine potentiation of brain stimulation reward reversed by DHβE and SCH 23390, but not by eticlopride, LY 314582 or MPEP in rats. Psychopharmacology 160, 56-66. (doi:10.1007/s00213-001-0953-6)
32. Jonkman, S., Risbrough, V. B., Geyer, M. A. & Markou, A. 2007 Spontaneous nicotine withdrawal potentiates the effects of stress in rats. Neuropsychopharmacology 33, 2131-2138. (doi:10.1038/sj.npp. 1301607)
33. Kellar, K. J., Dávila-García, M. I. & Xiao, Y. 1999 Pharmacology of neuronal nicotinic acetylcholine receptors: effect of acute and chronic nicotine. Nicotine Tob. Res. 1(Suppl. 1), S117-S120; discussion S139-S140. (doi:10.1080/14622299050011921)
34. Kenny, P. J. & Markou, A. 2001 Neurobiology of the nicotine withdrawal syndrome. Pharmacol. Biochem. Behav. 70, 531-549. (doi:10.1016/S0091-3057(01)00651-7)
35. Kenny, P. J. & Markou, A. 2004 The ups and downs of addiction: role of metabotropic glutamate receptors. Trends Pharmacol. Sci. 25, 265-272. (doi:10.1016/j.tips.2004.03.009)
36. Kenny, P. J. & Markou, A. 2005 Conditioned nicotine withdrawal profoundly decreases the activity of brain reward systems. J. Neurosci. 29, 6208-6212. (doi:10.1523/JNEUROSCI.4785-04.2005)
37. Kenny, P. J. & Markou, A. 2006 Nicotine self-administration acutely activates brain reward systems and induces a longlasting increase in reward sensitivity. Neuropsychopharmacology 31, 1203-1211.
38. Kenny, P. J., Gasparini, F. & Markou, A. 2003 Group II metabotropic and α-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats. J. Pharmacol. Exp. Ther. 306, 1068-1076. (doi:10.1124/jpet.103.052027)
39. Kenny, P. J., Chen, S. A., Kitamura, O., Markou, A. & Koob, G. F. 2006 Conditioned withdrawal drives heroin consumption and decreases reward sensitivity. J. Neurosci. 26, 5894-5900. (doi:10.1523/JNEUROSCI. 0740-06.2006)
40. Kenny, P. J., Chartoff, E., Roberto, M., Carlezon Jr, W. A. & Markou, A. In press. NMDA receptors regulate nicotine-enhanced brain reward function and intravenous nicotine self-administration: role of the ventral tegmental area and central nucleus of the amygdala. Neuropsychopharmacology.
41. Klitenick, M. A., DeWitte, P. & Kalivas, P. W. 1992 Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: an in vivo microdialysis study. J. Neurosci. 12, 2623-2632.
42. Lança, A. J., Adamson, K. L., Coen, K. M., Chow, B. L. C. & Corrigall, W. A. 2000 The pedunculopontine tegmental nucleus and the role of cholinergic neurons in nicotine self-administration in the rat: a correlative neuroanatomical and behavioral study. Neuroscience 96, 735-742. (doi:10.1016/S0306-4522(99)00607-7)
43. Levin, E. D. 2002 Nicotinic receptor subtypes and cognitive function. J. Neurobiol. 53, 633-640. (doi:10.1002/neu.10151)
44. Liechti, M. E., Lhuillier, L., Kaupmann, K. & Markou, A. 2007 Metabotropic glutamate 2/3 receptors in the ventral tegmental area and the nucleus accumbens shell are involved in behaviors relating to nicotine dependence. J. Neurosci. 27, 9077-9085. (doi:10.1523/JNEUROSCI. 1766-07.2007)
45. B receptor agonist and antagonists decreased brain stimulation reward in the rat. Neuropharmacology 40, 676-685. (doi:10.1016/S0028-3908(00)00204-5)
46. Mansvelder, H. D. & McGehee, D. S. 2002 Cellular and synaptic mechanisms of nicotine addiction. J. Neurobiol. 53, 606-617. (doi:10.1002/neu.10148)
47. Mansvelder, H. D., Keath, J. R. & McGehee, D. S. 2002 Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron 33, 905-919. (doi:10.1016/S0896-6273(02)00625-6)
48. Markou, A. 2007 Metabotropic glutamate receptor antagonists: novel therapeutics for nicotine dependence and depression? Biol. Psychiatry 61, 17-22. (doi:10.1016/j.biopsych.2006.03.053)
49. Markou, A. & Paterson, N. E. 2001 The nicotinic antagonist methyllycaconitine has differential effects on nicotine self-administration and nicotine withdrawal in the rat. Nicotine Tob. Res. 3, 361-373. (doi:10.1080/14622200110073380)
50. Marks, M. J., Burch, J. B. & Collins, A. C. 1983 Effects of chronic nicotine infusion on tolerance development and nicotinic receptors. J. Pharmacol. Exp. Ther. 226, 817-825.
51. Marks, M. J., Pauly, J. R., Gross, S. D., Deneris, E. S., Hermans-Borgmeyer, I., Heinemann, S. F. & Collins, A. C. 1992 Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. J. Neurosci. 12, 2765-2784.
52. Marks, M. J., Grady, S. R. & Collins, A. C. 1993 Downregulation of nicotinic receptor function after chronic nicotine infusion. J. Pharmacol. Exp. Ther. 266, 1268-1276.
53. McGehee, D. S. & Role, L. W. 1995 Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu. Rev. Physiol. 57, 521-546. (doi:10.1146/annurev.ph.57.030195.002513)
54. Moran, M. M., McFarland, K., Melendez, R. I., Kalivas, P. W. & Seamans, J. K. 2005 Cystine/glutamate exchange regulates metabotropic glutamate receptor presynaptic inhibition of excitatory transmission and vulnerability to cocaine seeking. J. Neurosci. 25, 6389-6393. (doi:10.1523/ JNEUROSCI.1007-05.2005)
55. Murray, C. J. & Lopez, A. D. 1997 Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 349, 1498-1504. (doi:10.1016/S0140-6736(96)07492-2)
56. Nisell, M., Marcus, M., Nomikos, G. G. & Svensson, T. H. 1997 Differential effects of acute and chronic nicotine on dopamine output in the core and shell of the rat nucleus accumbens. J. Neural Transm. 104, 1-10. (doi:10.1007/BF01271290)
57. Paterson, N. E. & Markou, A. 2002 Increased GABA neurotransmission via administration of gamma-vinyl GABA decreased nicotine self-administration in the rat. Synapse 44, 252-253. (doi:10.1002/syn.10073)
58. Paterson, N. E. & Markou, A. 2005 The metabotropic glutamate receptor 5 antagonist MPEP decreased break points for nicotine, cocaine and food in rats. Psychopharmacology 179, 255-261. (doi:10.1007/s00213-004- 2070-9)
59. Paterson, N. E., Semenova, S., Gasparini, F. & Markou, A. 2003 The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice. Psychopharmacology 167, 257-264.
60. B receptor agonists baclofen and CGP44532 decreased nicotine self-administration in the rat. Psychopharmacology 172, 179-186. (doi:10.1007/s00213- 003-1637-1)
61. B receptor-mediated regulation of brain reward function. Neuropharmacology 49, 953-962. (doi:10.1016/j.neuropharm.2005.04. 031)
62. Paterson, N. E., Froestl, W. & Markou, A. 2005b Repeated administration of the GABAB receptor agonist CGP44532 decreased nicotine self-administration, and acute administration decreased cue-reinstatement of nicotine-seeking in rats. Neuropsychopharmacology 30, 119-128. (doi:10.1038/sj.npp.1300524)
63. B receptors decreased nicotine self-administration and counteracted nicotine-induced enhancement of brain reward function in rats. J. Pharmacol. Exp. Ther.
64. Perry, D. C., Davila-Garcia, M. I., Stockmeier, C. A. & Kellar, K. J. 1999 Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies. J. Pharmacol. Exp. Ther. 289, 1545-1552.
65. Picciotto, M. R. & Corrigall, W. A. 2002 Neuronal systems underlying behaviors related to nicotine addiction: neural circuits and molecular genetics. J. Neurosci. 22, 3338-3341.
66. Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K. & Changeux, J. P. 1998 Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine. Nature 391, 173-177. (doi:10.1038/34413)
67. Quick, M. W. & Lester, R. A. 2002 Desensitization of neuronal nicotinic receptors. J. Neurobiol. 53, 457-478. (doi:10.1002/neu.10109)
68. Rowell, P. P. & Wonnacott, S. 1990 Evidence for functional activity of up-regulated nicotine binding sites in rat striatal synaptosomes. J. Neurochem. 55, 2105-2110. (doi:10.1111/j.1471-4159.1990.tb05802.x)
69. Royal College of Physicians of London 2000 Nicotine addiction in Britain: a report of the Tobacco Advisory Group of the Royal College of Physicians. London, UK: Royal College of Physicians of London.
70. Schwartz, R. D. & Kellar, K. J. 1983 Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo. Science 220, 214-216. (doi:10.1126/science.6828889)
71. Shiffman, S., West, R. J. & Gilbert, D. G. 2004 Recommendation for the assessment of tobacco craving and withdrawal in smoking cessation trials. Nicotine Tob. Res. 6, 599-614. (doi:10.1080/14622200410001734067)
72. B agonist baclofen modifies cocaine self-administration in rats. Behav. Pharmacol. 9, 195-206.
73. Skjei, K. L. & Markou, A. 2003 Effects of repeated withdrawal episodes, nicotine dose, and duration of nicotine exposure on the severity and duration of nicotine withdrawal in rats. Psychopharmacology 168, 280-292. (doi:10.1007/s00213-003-1414-1)
74. B receptor agonist baclofen attenuate the reward-facilitating effects of cocaine: intracranial self-stimulation studies in the rat. Neuropsychopharmacology 30, 2065-2072. (doi:10.1038/sj.npp.1300734)
75. Stolerman, I. P. & Jarvis, M. J. 1995 The scientific case that nicotine is addictive. Psychopharmacology 117, 2-10. (doi:10.1007/BF02245088)
76. Tapper, A. R. et al. 2004 Nicotine activation of α4* receptors: sufficient for reward, tolerance, and sensitization. Science 306, 1029-1032. (doi:10.1126/science.1099420)
77. Wang, F., Chen, H., Steketee, J. D. & Sharp, B. M. 2007 Upregulation of ionotropic glutamate receptor subunits within specific mesocorticolimbic regions during chronic nicotine self-administration. Neuropsychopharmacology 32, 103-109. (doi:10.1038/sj.npp.1301033)
78. Watkins, S. S., Stinus, L., Koob, G. F. & Markou, A. 2000 Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects. J. Pharmacol. Exp. Ther. 292, 1053-1064.
79. Wonnacott, S. 1990 The paradox of nicotinic acetylcholine receptor upregulation by nicotine. Trends Pharmacol. Sci. 11, 216-219. (doi:10.1016/0165-6147(90)90242-Z)
80. Wonnacott, S. 1997 Presynaptic nicotinic ACh receptors. Trends Neurosci. 20, 92-98. (doi:10.1016/S0166-2236(96)10073-4)